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1214-33 Safety of Low Molecular Weight Heparin After 
Transesophageal Echocardiographic Guided 
Cerdioversion as Bridging Therapy 
Deborah A. Hushes. Joseph F. Malouf, Brenda S. Moon, Naser A. Ammash, Paul A. 
Friedman, Krishnawaramy Chandrasedaran, Bernard J. Gersh, Mayo Clinic, Rochester, 
w 
Background: In patients undergoing transesophageal echocardiographic (TEE) guided 
cardioversion for atrial fibrillation of unknown or > 46 hours duration, the safety of post- 
cardioversion subcutaneous (sq) low molecular weight heparin (LMWH), in lieu of intra- 
venous unfractionated heparin, as bridging therapy until warlarin anticoagulation is thera- 
peutic (INR 2-3) is unclear. 
Methods: The Cardioversion Data Base from May 2000 through August 2002 was 
searched for patients dismissed home after successful TEE guided cardioversion on 
fixed doses of LMWH because of a sub-therapeutic INR. Patients wars followed up 
through clinical record review to identify any bleeding or cardioembolic events while on 
LMWH. 
Results: Eighty-one cases met our inclusion criteria and had complete follow up data (60 
men, 21 women; mean age 67 years +I- 13: 11 patients > 79 years). Eleven patients 
(13%) had a serum creatinine > 1.5 mg/dL. Eighteen patients received Ardeparin (130 U/ 
kg subcutaneously (sq) every twelve hours (ql2h). 14 received Enoxaparin (1 mgIkg sq 
q12h) and 45 received Dalteparin (100 U/kg sq q12h). Forty-nine patients had main- 
tained sinus rhythm at follow up (mean of 81 days). Bleeding complications occurred in 5 
patients (6.2%), all of whom were greater than 79 years old, comprising 45% of all 
patients in this age group. Three were major bleeds (two gastrointestinal and one retro- 
peritoneal) requiring hospitalization and blood transfusion. The INR was supra-therapeu- 
tic in one. Two were minor bleeds requiring no therapy. None had a serum creatinine > 
1.5 mg/dL. No patient experienced stroke or other systemic embolism while using 
LMWH. 
Conclusion: In this small cohort, no strokes or other systemic embolic events were 
observed in association with LMWH at doses used to treat acute deep venous thrombo- 
sis or pulmonary embolism. However, five bleeding complications ware observed in 
patients > 79 years of age. More data are needed. 
1214-34 Low Molecular Weight Heparin in Atrial Fibrillation Prior 
to Cardioversion: Short-Term Safety and Efficacy in a 
Transesophegeal Echocardiography Prospective Study 
Lydia Djaouti, Charles Smadja, Nadia Benyounes, Catherine Albo, Olivier Belliard. 
Franck Boccara. Ariel A. Cohen, Saint Antoine University, Paris, France 
Conventional treatment using wariarin (W) in atrial fibrillation (AF) before cardioversion is 
associated with a decreased thromboembolic (TE) risk. Currently, no echocardiographic 
study has been performed to evaluate the frequency of transoesophageal (TEE) TE risk 
markers under chronic W. We aimed at comparing TE markers in AF of > 2 days under 
W or low molecular weight heparin treatment (LMWH). 
Methods : Using transthoracic echocardiography and TEE, before cardioversion. wa 
compared 66 consecutive patients (Pts) under chronic W therapy (at least 3 weeks and 
INR > 2) to 140 consecutive Pts treated with subcutaneous weight adjusted LMWH 
(dalteparin) for instantaneous anticoagulation prior to cardiovewon. The following echo 
parameters were recorded : left (I-AA) and right (RAA) atrial appendage areas, spontane- 
ous echo contrast (SEC) and thrombus (Thr). 
Results : No difference was observed in the 2 groups with regard to age (66 f 12 and 70 
* 12 years, respectively), previous TE event (16 % and 9 %, respectively, p = 0.220) and 
cardiovascular risk factors. Valvular disease was more frequent in the W group (41 .I % 
and 16.5 %, respectively, p < 0.001). A comparison of the 2 groups is shown in the table. 
AFlWarfarin AFrLMWH P 
(n = 66) (n=140) 
In-hospital TE event 0 0 
LAA area (cm&#1 76;) 5.36 * 2.43 5.93 f 2.54 0.139 
LA SEC (n, %) 39 (57.3) 65 (60.7) 0.754 
RA SEC (n. %) 6 (11.7) 32 (22.6) 0.086 
LAA thrombus (n, %) 2 (2.9) 6 (4.2) 0.929 
Conclusion : No in-hospital TE event was observed. Embolic risk markers are present in 
chronic W group as well as in LMWF group. The prasancs of LAA Thr under W therapy 
suggests the need for TEE before cardioversion to exclude the presence of atrial 
thrombus in high risk Pts. 
. 
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1214-35 Thromboembolic Risk Stratification Based on SPAF 
Clinical Criteria in Patients With Paroxysmal Atrial 
Fibrillation and Flutter: A Prospective Transesophageal 
Echocardiography Study 
Nadia Benyounes. Lydia Djaouti, Charles Smadja. Catherine Albo. Olivier Bell&d, 
Franck Boccara, Ariel A. Cohen. Saint Antoine University, Paris, France 
It has been reported that patients (Pts) with paroxysmal atrial fibrillation and flutter (PAT) 
have a lower thromboembolic (TE) risk than those with permanent atrial fibrillation (AF). 
However, a recent longitudinal study suggested a similar annual rata of ischemic stroke 
in both populations. This apparent discrepancy could be explained by differences in the 
frequency of transesophageal echocardiography (TEE)-detected TE risk markers. 
Objective: We sought to assess TE risk markers using TEE in Pts with PAT according 
to the SPAF clinical criteria for risk stratification. 
Methods : As part of an ongoing study based on transthoracic and TEE in atrial arrhyth- 
mia, we prospectively studied 145 Pts within 46 hours of spontaneous cardioversion of 
any documented PAT (AF in 120 pts, atrial flutter or tachycardia in 25 Pts). Pts ware 
divided into high, moderate and low clinical risk groups. The following parameters ware 
evaluated : left atrial (LA) and LA appendage (LAA) areas, spontaneous echo contrast 
(SEC), LAA end diastolic emptying velocity (Vel), LAA thrombus (Thr) and thoracic aorta 
atheroma (TAA). 
Results : The main results are summarised in the table. 
Mean age (years) 
LA area @ml;) 
LAA area @I+;) 
LAA Vel 95 cm/s (II,%) 
LA SEC (II,%/.) 
LAA Thr (II,%) 
TAA -> 4mm (II,%) 
High risk Moderate risk Low risk P 
(rl=66) (n=34) (rl=45) 
77.9 * 9.9 63.6 -t 7.3 54.2 zt 15.3 <O.OOl 
19.9 * 5.6 19.3 * 4 18.3 * 5.5 0.937 
4.9 * 2.3 4.4* 1.7 4.6 + 1.9 0.987 
13 (20.6) IO (29.4) 13 (30) 0.460 
22 (35) 5 (15.1) 5(11.6) 0.007 
2 (3) 0 1 (2.2) 0.599 
15 (22.7) 5 (14.7) 2 (4.4) 0.031 
There was no difference in the 3 groups with regard to LA and LAA areas, Vel and Thr. 
,LA SEC and TAA wars significantly more frequent in high risk Pts using SPAF clinical 
criteria. 
Conclusion : These results suggest the need for a similar risk stratification and 
anticoagulant regimen in high-risk patients with PAT and permanent AF. 
1214-36 Recurrent lschemic Cerebral Events in Patients With 
Different Subtypes of Arterial or Cardiac Source of 
Embolism: A Four and Five-Year Follow-Up Study 
Stefano De Castro, Mauri& Rasura, llaria Passaseo, Filomena Di Lisl, Emanuele Di 
Angelantonio, Rosalba Patella, Alessandro Aiello, Francesco Fed&s, La Sapienza 
University, Rome, Italy 
Background This study was performed to assess the risk of recurrent ischemic events 
or death in stroke patients with different subtypes of arterial or cardiac source of embo- 
lism. 
Methods All patients admitted to the Department of Neurological Sciences underwent 
general medical and neurological examination, chest radiography, general blood chemis- 
try assay, CT scan, carotid ultrasound and transesophageal echocardiography. Patients 
discharged from the hospital have been followed-up for 5 years by clinical examination 
and telephone interview. In according to the modified criteria of Amarenco we divided 
patients in: Group I, those with a definite or possible arterial or cardiac source of embo- 
lism; Group II, with small-vessel disease; Group Ill, who could not be classified into either 
of the above groups. For the purpose of our study, Group I was further divided in patients 
with carotid artery disease, and definite, probable or possible source of emboksm (SOE). 
Results226 patients, mean age 55+17, male 51%, ware classified as follow: 152 (67%) 
in Group I, 60 (26%) in Group II and 16 (7%) in Group III. Overall recurrent stroke or 
death occurred in 34 (22%), 5 (6%) and 1 (6%) respectively in each group. 
During the observation period in Group I (mean age 57+17, male 51%) the recurrent 
rates was 43% for patients with definite, 17% for patients with probable, 20% for patients 
with possible causes of source of embolism and 21% for those with carotid artery dis- 
ease. In particular the highest recurrent rates of embolic events or death was observed in 
12 out of 27 (44%) patients with complicated aortic plaques and 12 out of 62 (19%) with 
atrial septal abnormalities determining right-to-left shunt. Conclusions: Patients with 
complicated aorta plaques on transesophageal echocardiography study are at increased 
risk for recurrence stroke or death. It suggests that these patients need a more aggras- 
sive treatment as opposed to those affected by other causes of ischemic stroke. 
1214-37 Predictors of Six-Month Sinus Rhythm Maintenance 
Following Successful Cardioversion of Atrial 
Fibrillation: An ACUTE Trial Ancillary Study 
John A. Sallach. Richard A. Grimm, Elizabeth Lieber, Carolyn Apperson-Hansen, Susan 
E. Jasper, Allan L. Klein, The Cleveland Clinic Foundation, Cleveland, OH 
Background: Clinical and transesophageal echocardiography (TEE) predictors of sinus 
rhythm (SR) maintenance following cardioversion of atrial fibrillation (AF) are poorly 
defined. The purpose of this study was to identify predictors of long-term SR mainte- 
nance following successful AF cardioversion. 
Methods: The Assessment of Cardioversion Using Transesophageal Echocardiography 
(ACUTE) Trial, randomized 1,222 patients with AF to TEE-guided cardioversion or con- 
ventional treatment. Successful conversion to SR occurred in 327 of 425 (60%) patients 
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undergoing cardioversion ~24 hours after TEE. At 6 months follow-up the presence of 
SR or AF was available in 276 patients. Baseline clinical variables and TEE parameters 
were compared between these Qroups. 
Results: At 6 months follow-up, 194 (70%) patients were in SR and 82 (30%) patients 
were in AF. Baseline clinical and TEE variables are displayed in Table 1 (’ p<O.O5). 
Patients in SR were statistically older (p=O.O2), and showed a trend towards having less 
congestive heart failure (CHF) (p=O.O8). SR patients also lacked severe mitral regurgita- 
tion (MR) (p=O.O04) and left atrial (LA) and left atrial appendage &AA) SEC (p=O.O2). 
LAA emptymg velocity was not associated with SR maintenance (p=O.86). 
Conclusions: At 6 months followup, age <= 70 yrs, absence of severe MR and lack of 
SEC predicted maintenance of SR following successful cardioversion of AF. Both clinical 
and TEE factors are useful in predicting SR maintenance 6 mos following AF cardiover- 
sion. 
Table 1. Predictors of Sinus Rhythm Maintenance at Six Months 
Atrial Fibrillation Smus Rhythm P value 
(“=82) (n=276) 
Age (years) 68+ 12 65*13 0.06 
Age > 70 years (%) 52% 37% 0.02’ 
Female (%) 32% 29% 0.63 
CHF (%) 38% 28% 0.06 
LA Diameter (cm) 4.9 * 1 .o 4.9 * 0.9 0.73 
LAA area (cm’) 6.1 r 2.7 5.8 * 3.2 0.36 
Maximum LAA Emptying Velocity (cm/set) 37 * 19 37+20 0.88 
Severe MR (%) 7% 1% 0.004 
LA & LAA SEC (%) 44% 29% 0.02’ 
1214-38 Effect of Mitral Regurgitation on Left Atrial Clot and 
Spontaneous Echo Contrast in Patients With Severe 
Mitral Stenosis 
Kewal C. Goswami. Anandaraja Subramania”, Rakesh Yadav, Kewal K. Talwar, All India 
Institute of Medical Sciences, New Delhi, India 
Background: The hypothesis that mitral regurgitation (MR) may prevent stasis of blood 
in left atrium (LA) and thus prevent spontaneous echo contrast (SEC) and clot formation 
I” patients with severe mitral stenosis (MS) remains to be established. 
Methods One hundred patients with severe MS (area < 1 .O cn?) and 2 mild MR (groupl) 
were prospectively compared with 200 patients with isolated severe MS (groupll) and 20 
controls. All the patients underwent transesophageal echocardiography for evaluation of 
LA/LA appendage (LAA) clot, SEC, and LAA function. (LAA - area, ejection fraction, LAA 
filling and emptying velocities and their velocity time integrals.) 
Results There was no significant difference in age, duration of symptoms, and mitral 
valve area in both the groups. Group I had significantly more atnal fibrillation, larger LA, 
and LAA area and significantly less SEC and LA clot compared to group II (Table). 
Comparison between MS and MR. Isolated MS and controls 
Group I Group II Control 
Atrial Fibrillation(%) 40 27.5t 
SEC(%) 36 56.5t - 
WLAA Clot (%) 8 25t 
LA Area ( cm 4 39.2+1X6 31.9*10.0t 13.0+2.1’$ 
LAA Maximal Area 7.5e2.6 6.0k2.47 2.8*0.7’$ 
(cm ? 
LAA Ejection Fraction (%) 37.1~10.8 35.8i15.6 61.1+10.2*$ 
LAA Emptying Velocity( cmlsec) 21.8+9.8 2O.li9.9 46.6tl8.4’$ 
LAA Filling Velocity( cmlsec) 29.5+13.1 25.lkl2.5 42.6+21.6’$ 
p significant between group I& group II (t); group I 8 control (‘); group II 8 control ($). 
LAA function parameters in both the groups were similar. In group I 40% had grade I & II 
MR and 60% had grade Ill and IV MR (scale of I to IV). No patient in group I had LA clot; 
all clots were in LAA and only with grade I &II MR. 
Conclusions Despite similarly depressed LAA function in both the groups, group I 
patients had significantly less LAA clot and SEC. We conclude that in group I presence of 
any degree of MR confers a protective effect on the development of LAA clot and SEC. 
This protective eflect was absolute with grade Ill 8 IV MR. 
1214-39 Relation Between Left Atrial Appendage Function and 
Abnormal Hypercoagulability in Patients With Atrial 
Flutter 
Kenli Sakurai, Tadakazu Hirai, Keiko Nakagawa. Tomoki Kameyama. Takashi Nozawa, 
Hidetsugu Asanoi, Hiroshi Inoue, Toyama Medical and Pharmaceutical University, 
Toyama, Japan 
Background: Thromboembolism might be hlgher than previously recognized for patients 
with atrial flutter (AFL) based on findings of transesophageal echocardiography (TEE). 
To evaluate the potential prothrombotic state in patients with AFL, TEE findings and 
hemostatic markers were compared among patient groups with AFL, normal sinus 
rhythm (NSR) and chronic nonvalvular atrial fibrillation (AF). Methods: In 33 patients 
(mean age 61 years) with AFL, 58 patients (88 years) wth AF, and 27 patients (61 years) 
with NSR who underwent TEE, plasma levels of markers for platelet activity (platelet fac- 
tor 4 (PF4) and Pthromboglobulin (PTG)), thrombotic status (thrombin-antithrombin Ill 
complex (TAT) and prothrombin fragments 1 and 2 (Fl+2)) and fibrinolytic status (D- 
dimer and plasmin-a2-plasmin inhibitor complex (PC)) were determined. Results: Tran- 
sthoracic echocardiography showed that left atrial (LA) dimension was larger in patients 
with AF than in those with NSR and AFL (AF. 45 * 1: AFL, 38 * I; NSR, 35 f 2 mm, 
~~0.01). There was no significant difference in left ventricular (LV) ejection fraction 
among the three groups. Prior embolic events and hypertension were observed more fre- 
quently in patients with AF than in those with AF than in those with NSR and 
AFL(peO.05). Left atrial appendage (LAA) blood flow velocity in patients with AFL was 
higher (~~0.01) than that in patients with AF. but was lower (pcO.01) than that in patients 
with NSR (AF. 25 f 2; AFL, 48 * 4; NSR. 60 i 4 cm/set). Dense LA spontaneous echo 
contrast (SEC) was found in 3 patients (9%) with AFL and 16 patients (28%) with 
AF(p<O.Ol). There was no significant difference in plasma levels of hemostatic markers 
between AFL group and NSR group. AFL patients with impaired LAA function (LAA flow 
< 30 cmlsec. dense SEC or both), however, showed higher level of D-dimer and P-TG 
than those without impaired LAA function (D-dimer; 2.0 * 0.8 vs. 0.4 * 0.1 pg/ml, PTG; 
80 * 22 vs. 34 t 7 @ml. pqO.05). Conclusions: Patients with AFL as a whole are not in 
the prothrombotic state as compared with those with AF. However, AFL patients with 
impaired LAA function are at potentially high risk for thromboembolism and might require 
intense anticoagulation. 
1214-40 Is Surgical Closure of the Left Atrial Appendage Useful 
for Preventing Cardioembolic Events? 
Birke Schneider, Claudia Stijllberger, Klinik fiir Kardiokgie, Stadt. Krankenhaus. Wbeck, 
Germany, II. Medizinische Abteilung. Krankenanstalt Rudolfstiftung. Wien, Austria 
Background: Closure of the fibrillating left atrial appendage (LAA) has been recom- 
mended during valve surgery to decrease the future risk of embolic events. However, 
patients undergoing surgical LAA closure have not consistently been reevaluated by 
transesophageal echocardiography (TEE) for complete LAA obliteration. 
Methods and Results: During a 7-month period, 5 female patients (age 72-81 years) 
with intermittent (n=2) or permanent (n=3) atrial fibrillation underwent surgical LAA clo- 
sure at the time of mitral and/ or aortic valve surgery. TEE performed 2345 days after 
the procedure demonstrated incomplete LAA closure in all patients due to disruption of 
the closure line and partial recanalization of thei sutured orifice. The size of the LAA ori- 
fice ranged from 3 to 20 mm. All patients demonstrated a relatively high flow velocity at 
the LAA orifice (0.33-2.2 m/set) whereas the flow in the LAA body was very low (~0.2 ml 
see). Compared to the preoperative TEE, spontaneous echocardiographic contrast was 
much more intense in the LAA body than in the LA cavity in all cases. In 1 patient a 
thrombus within the LAA was detected which had not bee” present on the preoperative 
TEE. One patient suffered a stroke 4 weeks after attempted LAA closure despite an opti- 
mal level of anticoagulation. 
Conclusion: Surgical LAA closure was incomplete in all patients, resulting in blood stag- 
nation and a” increased likelihood of clot formation. Facilitated by a high velocity jet, 
thrombi form the LAA may pass through the “arrow LAA orifice into the systemic circula- 
tion. Thus, incomplete surgical LAA closure may promote rather than reduce the risk of 
stroke. 
1214-41 Left Atrial Appendage Morphology: Comparison of 
Transesophageal Images and Postmortem Casts 
BStoellberper. Giinther Ernst, Elisabeth Banner, Josef Finsterer, J&g Slany. KA 
Rudolfstiftung, Wien, Austria 
Backgrounct The left atrial appendage (LAA) has a complex anatomy. Aim of the study 
was to compare I) transesophageal echocardiographic (TEE) measurements of LAA 
with postmortem LAA casts and 2) the accuracy of diagnosing LAA thrombi by TEE with 
postmortem findings. 
Methods and Results Included were 12 patients who underwent TEE and autopsy. By 
TEE, the LAA length, area and orifice diameter were measured and the LAA course and 
number of branches was estimated. The LAA casts were described regarding course and 
number of branches. The orifice diameter, the distance from orifice to apex and the cast 
volume were measured. TEE measurements of LAA length and area correlated well with 
the cast volume (r= 0.6 to r= 0.93). The TEE LAA orifice correlated better with the LAA 
cast orifice when measured in the horizontal @0.89) than in the longitudinal plane 
(r=O.46). TEE measurements of LAA area and length did not correlate well with the dis- 
tance from orifice to apex of the LAA casts. The agreement between TEE and LAA casts, 
concerning LAA course and the number of branches was only moderate. In one patient, 
a false positive diagnosis of a LAA thrombus OccurredConclusIon: LAA Size and orifice 
diameter can be assessed reliably by TEE, preferably in the horizontal plane. The com- 
plex LAA morphology hampers measurements of LAA length, branches, course and 
diagnosis of thrombi. 
1214-42 Age Related Changes in Left Atrial Size and Geometry 
Gerard P. Auriaemma Deepthi Mosali. Craig S. Vinch, Jeffrey C. Hill, Theo Meyer, 
Dennis A. Tighe, University of Massachusetts Medical School, Worcester, MA 
To investigate age-related changes in left atrial (LA) and left ventricular (LV) structure, 
we performed 2D directed M-mode echocardiography in 220 normal individuals from 19- 
84 years of age, and analyzed the data by age quartile. LA size was recorded in the stan- 
dard parasternal (PLA) view as well as in the apical view (A4c). Results: There were no 
significant differences between age quartiles with regard to height/weight/BSA or gender 
distribution. LV cavity dimensions declined with advancing age, while wall thickness and 
relative wall thickness (RWTd=P*posterior wall thickness/LVIDd)increased, leading to 
more concentric geometry. The diminution in LVlDd was offset by an increase in PWTd, 
so that LV mass index did not change significantly. In association with these LV changes, 
LA size Increased with advancing age in both the PLA and the A4c plane; accordingly, 
